An important prerequisite for the long-term success of SynAct Pharma AB, including any subsidiaries if applicable, (the “Company”) is the trust of its shareholders, business relations and the market in general. To maintain this trust, the Company must ensure that its activities are conducted in an ethical manner. This code of conduct (the “Code of Conduct”) established by the Company’s board of directors describes the general ethical principles in the Company’s business and the behaviour the Company expects of its employees.

The Code contains major principles in the areas described below and is mandatory for employees, management and board of directors:

  • Compliance with laws
  • Workplace
  • Safety and health
  • Environmental
  • Political activities
  • Confidential information
  • Insider trading
  • Anti-bribery and anti-corruption
  • Competition and anti-trust
  • Conflict of interest
  • Business partners
  • International trade controls
  • Financial reporting and records
  • Data privacy